Serbia takes steps towards western IVD (in vitro diagnostic)/device regulations
This article was originally published in Clinica
Serbia is now working on amending its medical device and diagnostic laws so that they are closely aligned with the EU's directives. But like Croatia, Serbia has been held back from joining the EU with the first wave of central and eastern European countries in 2004 by the aftermath of the war and the upheaval as it changes its political status.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.